Sequential

Sequential

Private
LondonHealthcare & Life Scienceshttps://sequential.bio

Last Round

Early Funding

Mar 17, 2026

Total Funding Raised

$7.95M

Momentum Score

50 /100

Company Overview

Sequential is a biotechnology company that provides an in-vivo microbiome testing platform for the personal care and pharmaceutical industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Fashion & Beauty, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

microbiome testingin-vivo clinical testingcontract research organizationCROclaims substantiationskin microbiome testingclinical trialscosmetic testingmicrobiome friendly testingresearch as a servicemulti-omicsmicrobiome sequencingproduct claim validationproduct certificationscalp microbiome testingoral microbiome testingvaginal microbiome testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sequential Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Sequential Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early FundingMar 17, 2026
GrantFeb 13, 2025
SeedMay 25, 2023
GrantJun 29, 2022
SeedOct 11, 2021
Pre Seed
Mar 17, 2021

Key People

Founding team and executive leadership

Oliver Worsley

Co-Founder CEO

Founding Team

Sequential Investors

Notable investors and investment history

InvestorRounds
Innovate UKGrant
Enterprise SingaporeGrant
Dermazone HoldingsEarly Funding
Innovate UKEarly Funding
Corundum Systems BiologyEarly Funding, Seed
IndieBioPre Seed
SparkfoodEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 17, 2026

    Raised $3.5M in early funding.

  • Mar 4, 2026

    Collected over 50,000 human skin microbiome samples.

Sequential Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sequential Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sequential's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range16
Year Founded2019
Last FundingMar 17, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.